Concepedia

Mikihiro Takamoto

MT

Statistics

Publications

2

Citations

43

H-Index

2

Active since

2020

Affiliations

Johnson & Johnson (Brazil)(Current)

Mikihiro Takamoto is an author at Johnson & Johnson (Brazil) specializing in adverse drug events, oxaliplatin-based therapy, and toxicity management.

Publications per year

2020–2025

2

Publications

2

Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab

Shaji Kumar, María-Victoria Mateos, Jing Christine Ye et al. · New England Journal of Medicine · 2025 · 23 citations

, , +17

A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathy

Masahito Kotaka, Yoji Saito, Takeshi Kato et al. · Cancer Chemotherapy and Pharmacology · 2020 · 20 citations · Full text

, , +17

1–2 of 2